CEVAC® TRANSMUNE IBD: Immune complex technology against IBD.
Infectious Bursal Disease (IBD) has been a long standing challenge in the field. Producers needed a vaccine that worked in the presence of a relatively high level of maternal antibodies.
In response, CEVA developed CEVAC® Transmune IBD, a unique vaccine utilizing upgraded immune complex technology that eliminated the difficulties of vaccinating for IBD by overcoming the challenge of when to vaccinate and the problem of non-uniform administration in the chicken house. It also made it possible to provide lifetime protection against all forms of IBD with a single dose administered via in ovo (in the egg) or subcutaneous injection.
VECTORMUNE®: The broadest range of disease protection in a vector vaccine line.
VECTORMUNE® vaccines are the next generation of poultry vaccines. These vector vaccines provide producers with all of the benefits of modified live vaccines without any of the disadvantages. VECTORMUNE® vaccines are genetically engineered to express key protective antigens against virulent poultry diseases including Newcastle Disease, Marek’s Disease, Fowl Pox, Gumboro, Avian Influenza, Avian Encephalomyelitis and Mycoplasma.
CEVAC® VITABRON L ®: Provides a unique solution for day-old vaccination.
The day-old vaccination of chicks is critical to achieve good priming and build a strong basis for the field life and possible revaccination against Newcastle Disease and Infectious Bronchitis.
However, it can induce detrimental post vaccination reaction in the young bird. To overcome this problem, CEVA developed a unique vaccine combination of PHY.LMV.42 apathogenic enterotropic strain of Newcastle Disease virus and the Massachusetts H120 strain of Infectious Bronchitis virus that allows a safe and efficacious spray application at day-old in the hatchery.
LAYERMUNE® SE: Still setting the standard in salmonella protection.
CEVA received the first USDA license for a poultry vaccine against S. enteritidis. Introduced in 1992, LAYERMUNE® SE has been instrumental in earning CEVA the #1 ranking in salmonella vaccines in the U.S. With the concern of S. enteritidis to human health, the proven efficacy of LAYERMUNE® SE quickly expanded CEVA’s worldwide reach.
CEVAC CORYMUNE ® RANGE: Broad spectrum Infectious Coryza and Salmonella Enteritidis (SE) vaccine
Reducing the number of vaccinations by combining the protection of Infectious Coryza, main viral diseases and SE in one vaccine:
CEVAC ® Corymune 4K is the first inactivated vaccine combining broad Infectious Coryza protection (serotype A, B, C) and SE in one vaccine. The vaccine is with an Aluminium Hydroxide adjuvant for undisrupted growth in pullets.CEVAC ® Corymune 7K long lasting immunity during the egg production period by combining protection against Infectious Coryza (serotypes A, B, C), SE, Infectious Bronchits, Egg Drop Syndrome and Newcastle disease.
All the detailed information about the CEVA Poultry Vaccines range is also available on "The Poultry Site" by clicking here
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.